CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (27,019,774)	$ (28,493,958)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	165,920	185,245
Stock-based compensation	3,310,125	4,769,179
Changes in operating assets and liabilities:
Incentive and tax receivables	7,449,915	(361,104)
Prepaid expenses and other assets	(637,578)	1,424,002
Right-of-use assets and liabilities	947	(7,858)
Accounts payable	(256,554)	113,634
Accrued expenses	(354,500)	(3,252,118)
Net cash used in operating activities	(17,341,499)	(25,622,978)
Cash flows from investing activities:
Purchases of property and equipment	(146,705)	(47,570)
Net cash used in investing activities	(146,705)	(47,570)
Cash flows from financing activities:
Proceeds from the issuance of common stock	6,059,511	43,193,660
Payment of financing fees and expenses	(444,816)	(1,085,707)
Proceeds from the exercise of stock options		47,906
Net cash provided by financing activities	5,614,695	42,155,859
Net (decrease) increase in cash and cash equivalents	(11,873,509)	16,485,311
Cash and cash equivalents at beginning of period	67,808,000	59,157,187
Cash and cash equivalents at end of period	55,934,491	75,642,498
Supplemental disclosures of cash flow information:
Financing costs included in accounts payable and accrued expenses at end of period	122,782	$ 42,500
Property and equipment acquired but unpaid at end of period	$ 53,245